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Echovirus 13 (EV13), considered rare, was reported
worldwide in 2000, mostly related to aseptic meningitis out-
breaks. In Spain, 135 EV13 isolates were identified. The
genetic relationships between 64 representative strains
from Spain and other reported isolates from the United
States, Germany, Italy, Japan, and Sweden were described
by analyzing the partial sequence of the major capsid pro-
tein (VP1) gene. The strains from Spain were clearly iden-
tified as EV13 (79.5% similarity with the EV13 reference
strain) and were grouped phylogenetically into two different
clusters (by origination on either the Iberian Peninsula or
Canary Islands). Isolates from Germany from 2000 clus-
tered with the Canary Islands group. The isolates from
other countries obtained before 2000 were genetically dis-
tant. Changes in EV13 coding sequence involved several
differences in the C-terminal extreme of the VP1 protein.
Part of the neutralizing antigenic site III has been described
in this genome region in poliovirus and swine vesicular dis-
ease virus.
T
he human enteroviruses (HEVs; Enterovirus [ENV]
genus,  Picornaviridae family) are common human
pathogens with a worldwide distribution. HEVs are found
in temperate climates and especially in the tropics because
warm weather favors their spread. Humans are the only
known reservoir for HEV, and the main transmission route
is fecal-oral. HEV infections may be unapparent or related
to different disorders, including encephalitis, pleurodynia,
myocarditis, conjunctivitis, or systemic infections in
neonates. These viruses are commonly reported in associ-
ation with aseptic meningitis outbreaks in pediatric
patients (1). Although five HEV species exist (2), they are
grouped into four clusters (HEV-A, -B, -C, and -D) on the
basis of  sequence analysis of the major capsid protein
(VP1) and the 3′ noncoding region (3). The HEV-B cluster
includes  coxsackie virus B (CBV), coxsackie virus A9,
ENV69, and all echoviruses (EV). 
The advent of nucleic acid amplification methods has
facilitated the study of the molecular epidemiology of
HEV (4–6). Several reverse transcription-polymerase
chain reaction (RT-PCR) methods were developed for this
purpose, most of which analyze different sequence frag-
ments within the VP1 gene (7–9). Moreover, the amplifi-
cation and subsequent analysis of the VP1 3′ end partial
gene have been successfully used to serotype HEVs
(10,11) and to describe the molecular epidemiology of
EV30 (12). Analysis of this fragment of the enteroviral
genome has permitted the study of important pathogenic
structures, such as part of the antigenic sites described for
polioviruses (13), CBV, and swine vesicular disease virus
(SVDV) (14,15), and part of the canyon structure, related
to viral attachment, which has been described in several
HEVs and rhinoviruses (16).
The EV strains most frequently isolated in patients with
aseptic meningitis are EV30, EV6, EV11, and EV9 (1).
Displacement of prevailing lineages on the basis of
immune escape (antigenic drift) has been suggested for
EV30 as the mechanism to maintain viral circulation lev-
els that increase periodically (12,17,18). Unlike EV30,
EV13 has been considered a rare virus (1). Until 1999, iso-
lation data showed very low rates in countries such as the
United States (19), Ireland (20), and England and Wales
(21). During 2000, EV13 circulation, mostly related to
aseptic meningitis, was reported in America (19), Europe
(20,22–25), Asia (26), and Australia (27). In Spain, an out-
break of aseptic meningitis attributable to EV13 occurred
from February to October 2000 (25), the first identification
of this virus in Spain since record keeping began in 1988
(28). 
We describe the molecular epidemiology of the EV13
isolates obtained in Spain from the 2000 outbreak by ana-
lyzing the VP1 partial sequences of 64 identified viruses.
We also compare them with other isolates for which
sequences have been deposited in databases. Finally, by
analyzing the molecular nature of their changes in
nucleotides and amino acids, we attempt to describe the
nature of, and reasons for, the actions and epidemiology of
EV13.
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Clinical Specimens
Study specimens consisted of 61 EV13 isolates and
three cerebrospinal fluid (CSF) samples obtained as fol-
lows. During 2000, the Enterovirus Laboratory (Service of
Virology, National Microbiology Centre, Madrid) received
538 isolates for typing from different laboratories within
Spain. These viruses were mostly recovered in a human
rhabdomyosarcoma cell line with a positive cytopathic
effect, which was  confirmed by immunostaining with an
anti-HEV group-specific antibody (Dako, Glostrup,
Denmark). A neutralization test (Lim-Benyesh-Melnick
immune serum pools) identified EV13 in 135 (25%) spec-
imens. On the basis of their geographic and temporal dis-
tribution (Figure 1), 61 isolates were selected for further
study. The selected isolates were obtained from CSF
(n=44), stool (n=12), and pharyngeal swab (n=5) samples
from patients with aseptic meningitis, except for samples
from seven patients who had fever, one who had acute
flaccid paralysis, and two healthy persons (contacts of the
patients with acute flaccid paralysis). The outbreak was
carefully studied in the Canary Islands because of the high
rate of infected patients and the context in which the cases
occurred, including geographic location, climate, and
tourism activity in the area during the year. Three addition-
al CSF samples obtained from patients with aseptic menin-
gitis in March 2000 were supplied by the Microbiology
Diagnostic Service (National Microbiology Centre,
Madrid, Spain).
Amplification 
The VP1 3′ end genome region, successfully used to
study the molecular epidemiology of other HEVs (7,12),
was amplified in all 64 isolates. A609-nucleotide (nt) frag-
ment was amplified by using the RT-nested PCR method
(10) with a total of 5 µL of each 1:10 diluted cell culture
isolate. A fragment of the expected length was also
obtained in the three additional CSF samples, previously
extracted with guanidinium thiocyanate lysis buffer (29).
The VP1 3′ end fragment was useful in differentiating
and studying the epidemiology of HEVs. However, since
our main goal was to compare the sequences of the
Spanish isolates with those of isolates from the rest of the
world, we designed a specific PCR to amplify the VP1 5′
end gene, where a collection of isolates from Germany had
been sequenced (22). For that purpose, specific primers of
EV13 were designed by using the multiple alignments con-
structed with the available EV13 sequences employing
Clustal X software (free software available from: URL:
http://www-igbmc.u-strasbg.fr/BioInfo/). The primer
sequences were as follows: EV13_VP1sense (5′–3′) TGA-
GACAGGGCACACATC; EV13_VP1anti (5′–3′)
GCTAATGAATGGGATGGACAT. Its relative positions to
EV11 polyprotein genome (X80059) were 2560–2577 and
2999–3019, respectively. Single-step RT and amplification
was performed by using the Access RT-PCR kit (Promega
Corp., Madison, WI). Five microliters of selected 1:10
diluted cell culture isolates was added to the reaction mix-
ture which contained the following: 10 µL of 5X reaction
buffer; 2 mM magnesium sulfate; 250 µM each of dATP,
dCTP, dGTP, and dTTP; 0.4 µM of each EV13_VP1sense
and EV13_VP1 anti-primers; 1 U of avian myeloblastosis
virus RT; and 1 U of thermus flavus DNA polymerase and
Rnase-free distilled water to a final volume of 50 µL.
Amplification was performed in a PTC-200 Peltier thermal
cycler (M.J. Research, Inc., Waltham, MA), programmed
for a first RT step of 45 min at 48°C, followed by 2 min at
94°C, and for 45 cycles of 30 sec for denaturation at 94°C,
2 min for annealing at 60°C, and 30 sec for elongation at
68°C. Elongation was extended for 5 additional minutes in
the last cycle. PCR products were detected by elec-
trophoresis on 2% agarose gels stained with ethidium bro-
mide. A 460-nt fragment was amplified in 14 representa-
tive selected Spanish isolates.
Sequencing and Sequence Analysis
Cycle sequencing reactions of products from both RT-
PCR assays were performed by using the Big Dye termi-
nator kit (Applied Biosystems, Foster City, CA).
Ambiguities were resolved by sequencing both sense and
antisense strands. 
The 423-nt VP1 3′ end fragment (nt 2912–3334,
according to the EV11 polyprotein genome, X80059) was
analyzed through the multiple sequence comparison of the
64 viral sequences from Spain, the EV13 and ENV69 pro-
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Figure 1. Temporal distribution of the Spanish echovirus 13 iso-
lates during 2000. The isolates were grouped attending to their
geographic origin as from the Iberian Peninsula and from the
Canary Islands. The number of viruses included in the study (in
parentheses) as well as the total isolates per month are shown.
*Includes three sequences obtained directly from cerebrospinal
fluid.totype strains (Del Carmen and Toluca-1, respectively),
and the isolates VA86-6776 (30) and TX95-2089 (7). For
the analysis of the 279-nt VP1 5′end fragment (nt
2609–2887, according to the EV11 polyprotein genome,
X80059), sequences available from GenBank of the fol-
lowing isolates were included: 12 isolates from Germany,
obtained during 1965, 1974, 1976, 1979, 2000, and 2001;
one isolate each from Italy (1996) and Sweden (1999), and
two from Japan (2001). This second group of sequences
was compared with the corresponding VP1 5′ end gene of
14 Spanish representative isolates selected according to
their geographic origin (four from the Canary Islands and
within the Iberian Peninsula, four from the north, four
from the center of the peninsula, and two from the east).
Multiple sequence alignments were built with Clustal
X. For the molecular typing, Spanish VP1 3′ end gene
sequences were compared pairwise with the HEV proto-
type strains to obtain the identity score (11). The percent-
age of similarity of the isolates with respect to the refer-
ence strain was calculated through Megalign software
(DNASTAR, Madison, WI).
The phylogenetic tree in Figure 2 was reconstructed
through the neighbor-joining method (MEGA version 2.1
software package; available from URL: http://www.mega-
software.net) by using Kimura two parameters as substitu-
tion model, with statistical significance of phylogenies
estimated by bootstrap analysis with 1,000 pseudoreplicate
datasets. The transition-transversion ratio employed
(TRatio=2) was estimated through the Tree-puzzle version
5.0 software (available from: URL: http://www.tree-puz-
zle.de). Genetic distances were calculated using the same
model of nucleotide substitution. The distance matrix was
recorded and the pairwise observed distance values were
employed to define different subgroups and to build the
histogram in Figure 3. The analysis of variance one-way
test, with a statistical significance value of 0.05, was used
to compare the means of the pairwise observed distance
value matrix. To reconstruct the phylogenetic tree shown
in Figure 4, the maximum-likelihood method (DNAML
program, PHYLIP software [available from: URL:
http://evolution.genetics.washington.edu]), was used, with
hidden Markov as the model of nt substitution. A Poisson
correction model was used to compare the amino acid
sequences.
Three-Dimensional Structure
The VP1 amino acid changes of the Spanish isolates
with respect to the EV13 reference strain were projected
onto the three-dimensional structure of EV11 (GenBank
1H8TA) (31) by using the program Cn3D (available from:
URL: http://www.ncbi.nlm.nih.gov/Structure). Neutral-
izing antigenic sites previously reported for poliovirus
(13), CBV4 (32), and CBV5 and SVDV (14,15) were
localized in the structure. Amino acids were numbered
according to EV11 sequence.
Nucleotide Sequence Accession Numbers
Fourteen complete gene sequences of Spanish EV13
VP1 were submitted to the GenBank database under
accession numbers AY227334–AY227347. Fifty Spanish
EV13 VP1 3′ end fragments were also submitted under
accession numbers AY227284–AY227333. These EV13
sequences were also included in this study: AF081327
(Del Carmen), AJ309256 (Roma96), AF401360
(Halle74), AF401359 (Postdam76), AF401358
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Figure 2. Phylogenetic tree of the VP1 3' terminal region, which
identifies the Spanish isolates as echovirus 13 (EV13) and differ-
entiates two clusters (Iberian Peninsula and Canary Islands). The
sequences included are, apart from the reference strains, all the
Spanish EV13 (61 isolates and 3 sequences obtained directly from
cerebrospinal fluid) and two American isolates. Model of
nucleotide substitution: Kimura two parameters. Phylogenetic tree
reconstructed with the neighbor joining method, and bootstrap
analysis with 1,000 pseudoreplicate datasets.(Postdam79), AF401357 (Berlin65), AF401356
(Chemniz00), AF401355 (Krefeld00), AF401354
(Stuttgart00), AF401353 (Ulm00), AY007223
(Weissenfels00), AF295467 (Sweden99), AF152299
(VA86-6776), AF081635 (TX95-2089), AB092985
(JA1CR0210F), AB092984 (JA1ON022R), AY131288
(KASS31001), AF538285 (DRES41001), and AF538284
(MARD37701). The sequence AF081349, corresponding
to the ENV69 strain Toluca-1, was also included as the
nearest possible taxon and outgroup. GenBank accession
numbers of the rest of the VP1 partial gene of HEVs pro-
totype strains have been detailed previously (7). 
Results
Molecular Typing of Isolates
A preliminary multiple sequence alignment, as
described by Palacios et al. (11), grouped all the Spanish
viruses with the EV13 reference strain with 79.5% identi-
ty (SD [standard deviation] 0.37). ENV69 reference strain
was the nearest taxon with 74.3% (SD 0.33) identity; the
rest of the HEVs shared <71%. In addition, pairwise
sequence distance comparison showed that all the isolates
from Spain differed from the EV13 and ENV69 reference
strains with observed nucleotide distances of 0.260 (stan-
dard error [SE] 0.028) and 0.344 (SE 0.032), respectively.
Consequently, all the Spanish isolates were classified as
EV13, in agreement with the neutralization test results.
Comparison of the Nucleic Acid 
of the Spanish Sequences
Spanish isolates grouped into two major clusters corre-
sponding to their respective geographic origin (Iberian
Peninsula and Canary Islands) with statistical significance
(Figures 2 and 3). The 10-nt changes that determined the
groups were all in third codon position. The nucleotide dis-
tances observed within the Canary Islands sequence group
ranged from 0 to 0.022, whereas within the Iberian
Peninsula group, the range was from 0 to 0.029. The dis-
tance range obtained after comparison of sequences
belonging to these different groups was 0.024–0.052. The
study of the temporal pattern of the Spanish outbreak sug-
gests that, although all the Spanish isolates have a common
source, the group from the Canary Islands might be closer
to the ancestor.
Comparison of the Spanish Isolates with Other
Available EV13 Sequences
EV13 viruses isolated in 2000 and 2001 from Germany,
Japan, and Spain were phylogenetically close. Within all of
the studied sequences, the more similar ones, with a
nucleotide distance of 0.011, corresponded to the strains
isolated in Germany and the Canary Islands in 2000. The
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Figure 3. Histogram of the observed distances (Kimura two param-
eters method) within Canary Islands and Iberian Peninsula groups
(dark gray) and between them (light gray). Analysis of variance
(ANOVA) (one-way) test results: F=5238 (p=0.000). Distances
within homologous groups: Canary Islands: mean 0.008 (standard
deviation [SD] 0.004; n=351); Iberian Peninsula: mean 0.010
(SD0.006; n=666). Distances between heterologous groups
(black): mean 0.033 (SD 0.005; n=999).
Figure 4. Phylogenetic tree of the 5' VP1 extreme showing the
relationship between the Spanish isolates and others. The
sequences included are the 14 Spanish echovirus 13 selected iso-
lates as well as the German (n=12), Italian (n=1), Swedish (n=1),
and Japanese (n=2) isolates. Phylogenetic tree reconstructed with
the maximum-likelihood method, 50 Jumble. Gray sequences cor-
respond to the 2001 isolates.study of the temporal pattern by the maximum-likelihood
approach also grouped the German 2000 isolates with the
Spanish ones (Figure 4).
For the European strains, obtained before 2000, the iso-
lates were genetically more distant from the Spanish iso-
lates; the 1999 strain from Sweden was the second most
similar to the Spanish isolates, followed by the isolate
from Italy (1996) and those from Germany (1979, 1976,
and 1965). The two strains from the United States (VA86-
6776 and TX95-2089) were the most distant from the
Spanish isolates, with a genetic distance of 0.345 and
0.311, respectively (Figure 2). These two viruses seemed
to be as similar to ENV69 as to EV13. Further sequence
analysis of other strains of American EV13 and additional
ENV69 isolates could clarify this point. However,
although no other ENV69 sequences were available for
comparison, we could confirm that these sequences did not
cluster into the same evolutionary lineage of all other pub-
lished EV13.
Comparison of Amino Acid Sequences
Several amino acid differences could be observed
between the Spanish isolates and the EV13 reference
strain. The EV13 neutralization sites have not been deter-
mined. However, they have been reported for other ENVs
and some of them (sites I and III) are in the same position
and have the same amino acids involved. For this reason,
the amino acid changes noticed in this study and neutral-
ization sites previously reported for other ENVs were pro-
jected on the three-dimensional EV11 structure (Figure 5).
The possible relationship between them was detailed;
however, we can only speculate about whether EV13 neu-
tralization sites were affected or not. Two changes, A100V
and F238I, were structurally close to known neutralization
site I described for poliovirus (13), CBV4 (32), and CBV5
and SVDV (14). However, in most cases the amino acid
differences were located in the VP1-2A junction (S274A,
T276P, N284S, P285T, A286G, S287G, K288R, M290V,
N291T, and H292N), affecting a region that was consid-
ered part of the neutralizing antigenic site III for SVDV
(15). The amino acid changes (S274A and T276P) implied
a change in the properties from hydrophilic to hydrophobic
residues. These two positions were also different from the
reference strain in the two U.S. isolates; however, they did
not result in amino acids with hydrophobic characteristics
(T276D/E). 
Apart from the American isolates, the comparison of
the amino acid sequence for EV13 isolates with respect to
the reference strain was only possible in the amino termi-
nal part of the VP1 protein. In this region, changes were
identified in the strains that dated from 1965 to 1979,
mostly affecting amino acids that have been considered as
part of the neutralizing antigenic site I in poliovirus (D84S
and A85D/E) (13). Only one amino acid (M216I) differed
between the two Spanish clusters. This position was not
related to any known antigenic site.
Discussion
After a 12-years period in which EV13 circulation in
Spain was not detected, a virus identified through neutral-
ization test as EV13 began to be isolated in CSF of patients
with aseptic meningitis. These isolates were also clearly
identified as EV13 serotypes through molecular typing by
their substantial homology with the EV13 Del Carmen
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Figure 5. Mapping of the echovirus (EV) 13
VP1 amino acids. The three-dimensional
structure is projected onto EV11 structure
(GenBank accession no. 1H8TA) with VP1
amino acid numbering according to EV11. The
sequenced fragment is shown in red.
Previously reported neutralizing antigenic
sites for poliovirus, CBV4, and SVDV are
shown in yellow. The enterovirus canyon
structure is depicted in a similar location to the
canyon structure of poliovirus as reported by
(40).prototype strain. The viruses could also be identified
directly from most of the CSF samples assayed (three of
them included in this study; other data not shown) without
the need of isolation, demonstrating the utility and reliabil-
ity of the ENV molecular typing according to the VP1
homology with respect to the reference strains (11).
Indeed, the molecular study was successfully completed,
despite the high degree of genetic differences between the
EV13 recent isolates and the prototype strains of EV13 and
ENV69, which were isolated in the Philippine Islands in
1953 and in Mexico before 1973, respectively.
Phylogenetic analysis of the nucleotide sequences
showed that the Spanish strains were clustered into two
distinct groups, those from the Canary Islands and those
from the Iberian Peninsula, coinciding with their geo-
graphic origin. The first aseptic meningitis case caused by
EV13 was described in the Canary Islands in February
2000. The distinctness of the groups was indicated by sev-
eral silent nucleotide changes and one amino acid change,
which apparently developed in a short period (the initial
isolate of both groups was obtained about 1 month apart);
for this reason, we cannot rule out the possibility that both
groups could have had a common form but different ances-
tor. The special climate of the Canary Islands could explain
the winter appearance of the cases (first case February 14).
When both Spanish clusters were genetically compared
with isolates from other geographic origins, the EV13
strains from the Canary Islands appeared more closely
related to the German isolates of 2000. This may reflect the
introduction of EV13 from the Canary Islands into north-
ern Europe (or vice versa) through tourist travel. The
European isolates (Swedish, Italian, and German) obtained
before 2000 presented nucleotide distances in respect to
the Spanish isolates that increased over time. On the other
hand, the two American strains, obtained in 1986 and
1995, showed the most distance between isolates. Indeed,
the Spanish isolates showed larger differences with respect
to the American isolates than those identified with the rest
of the available EV13 sequences. In addition, the
American strains of EV13 seem to be unrelated to the
EV13 strains reported in the rest of the world; these
American strains may represent another evolutionary line-
age of this serotype. As a result, European and American
EV13 strains could be assigned to different subgroups, in
contrast to EV30 strains, which do not seem to be restrict-
ed geographically (12). However, more U.S. isolates from
the same period would be necessary to define a consistent
subgroup. Yet, preliminary data show that the reported
U.S. isolates from 2001 may be genetically close to the
European isolates (33). 
The correlation between the genetic distance and the
time parallels the behavior of such other epidemic viruses
as EV30 (12), EV7 (34), EV25 (5), and ENV71 (35).
However, these viruses usually maintain their isolation
rates and increase their circulation periodically (28). In
contrast, EV13 was isolated infrequently throughout the
world until 2000, when isolation rates increased dramati-
cally in several countries in association with aseptic
meningitis outbreaks. This type of presentation was previ-
ously described in other HEVs such as EV4, which caused
a large aseptic meningitis outbreak in 1997 in Israel (36).
This behavior may be due to a genetic and antigenic drift
that changes the virologic properties of the isolates.
However, EV13 may simply be rare, and artifacts of sur-
veillance or identification may have led to its seemingly
sudden appearance. In consequence, viruses could have
increased in virulence or improved their pathogenic mech-
anisms by antigenic change, despite the fact that they were
able to be neutralized in vitro with horse-specific serum.
However, further study is needed to investigate their anti-
genic characteristics, the human immune response to
EV13,  and whether a change in virulence occurs. The
study of the VP1 genome region permitted us to observe
the characteristics of the major capsid protein, which may
be involved in this type of process, together with the rest
of structural proteins. However, other genome changes,
including those affecting replication (37,38), may also be
implicated; thus, to understand the molecular epidemiolo-
gy of HEV outbreaks, molecular studies of other regions of
the genome are indicated. 
Changes in EV13 coding sequence involved several
differences in the C-terminal extreme of the VP1 protein,
known to be highly variable and containing neutralizing
antigenic site III in SVDV (15). Similar alterations have
been related to positive selection affecting other ENV as
EV30 (12), determining its evolution over the time. These
amino acid changes in EV13 VP1 protein could be
involved in the notable increase in the number of isolations
of these viruses, since they were able to cause aseptic
meningitis outbreaks worldwide (19–23,25,27,39).
Moreover, although the isolates were successfully neutral-
ized in vitro with the Lim-Benyesh-Melnick immune
serum pools, the amino acid changes affecting VP1 should
be taken into account during the evaluation of the neutral-
ization test results. The only amino acid change between
the two mentioned Spanish groups (M216I), which entails
a change of a hydrophilic amino acid into a hydrophobic
one, might confer some biologic advantage. It is not relat-
ed to any neutralizing antigenic site previously described
for ENVs, but might be related to the canyon structure,
since this position is located in the floor of this structure in
polioviruses (40). However, further research on the inter-
action between the cellular receptor and EV13 canyon
should address this point. The canyon structure is a capsid
surface depression described in several ENVs and rhi-
noviruses (16) that has been reported to join different cel-
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(31) indicate that differences of few amino acid residues of
the viral surface affecting the canyon structure may change
the infectivity of the virus dramatically.
The molecular epidemiology of EV13 presents similar-
ities and differences with other HEVs. The studies to date
have demonstrated an epidemic pattern in viruses related
with outbreaks such as ENV70 and EV30. This pattern
suggests a unique strain of virus causing outbreaks all over
the world similar the epidemics attributable to influenza A
and B viruses. 
However, since the human population is believed to be
the only ENV reservoir, this pattern should be completed
with the continuous isolation of the agent over nonepidem-
ic years. This type of circulation has been observed in sev-
eral HEVs, such as EV30 or EV9 but has not been
observed in the case of EV13 or other rare HEVs.
However, EV13 may have been circulating in the popula-
tion at undetectable levels or in a nonpathogenic way.
Since HEVs are usually typed only when they are related
to unexpected outbreaks, a nonpathogenic virus could cir-
culate in the population for a number of years before caus-
ing outbreaks. 
The circulation of EV13 in Spain seem to have sudden-
ly stopped. Since October 2000, over 700 ENV isolates
have been typed in the Spanish Enterovirus Reference
Laboratory, and only 1 imported EV13 isolate (data not
shown) was detected in 2001 in a tourist from the Czech
Republic who was visiting the Canary Islands.
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